Company Ziamed & Research S.r.l. with Fiscal Code 18198360
recorded a turnover of 2024 of
4.844,
with a net profit of
648
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă spitalicească having the NACE code 8610.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ziamed & Research S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
65.083
93.343
35.738
0
0
0
6.166
11.461
9.952
4.844
Total Income - EUR
65.083
95.124
1.163.239
18
0
827
6.166
11.525
10.572
4.844
Total Expenses - EUR
43.933
91.598
466.301
13.383
13.237
11.333
5.605
11.100
10.155
3.870
Gross Profit/Loss - EUR
21.150
3.526
696.938
-13.365
-13.237
-10.505
561
425
417
974
Net Profit/Loss - EUR
19.198
2.575
600.963
-13.365
-13.237
-10.530
500
318
319
648
Employees
3
4
3
0
0
0
2
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -51.1%, from 9.952 euro in the year 2023, to 4.844 euro in 2024.
The Net Profit increased by 330 euro, from 319 euro in 2023, to 648 in the last year.
Check the financial reports for the company - Ziamed & Research S.r.l.
Financial Rating - ZIAMED & RESEARCH S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ziamed & Research S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ziamed & Research S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ziamed & Research S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ziamed & Research S.r.l. - CUI 18198360
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
177.295
168.920
113.641
103.736
94.060
84.754
81.164
156.443
267.711
266.215
Current Assets
180.030
129.418
678.680
240.126
217.388
211.955
206.692
136.639
220.065
202.776
Inventories
0
0
0
5.759
5.648
5.541
6.894
5.434
5.418
5.388
Receivables
176.435
127.489
5.893
7.076
7.371
7.371
6.036
32.140
66.821
46.764
Cash
3.595
1.929
672.786
227.292
204.369
199.043
193.762
99.065
147.826
150.624
Shareholders Funds
122.712
124.040
637.274
306.841
287.662
271.678
266.154
267.298
266.806
265.962
Social Capital
9.966
9.869
9.702
9.524
9.340
9.163
8.959
8.987
8.960
8.910
Debts
177.606
142.901
177.374
56.612
40.713
39.398
33.562
37.681
33.194
16.804
Income in Advance
57.103
56.521
0
0
0
0
0
0
199.636
198.520
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8610 - 8610"
CAEN Financial Year
6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
202.776 euro in 2024 which includes Inventories of
5.388 euro, Receivables of
46.764 euro and cash availability of
150.624 euro.
The company's Equity was valued at
265.962 euro, while total Liabilities amounted to
16.804 euro.
Equity increased by 648 euro, from 266.806 euro in 2023, to 265.962 in 2024.
The Debt Ratio was 3.5% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ziamed & Research S.r.l.